BRUSSELS (Thomson Financial) - Belgian healthcare group OncoMethylome
Sciences NV. said it has signed an agreement with Laboratory Corporation of
America Holdings (LabCorp) to supply reagents for detecting colorectal cancer.
Under the terms of the agreement, OncoMethylome will earn revenue for
supplying the reagents and will receive milestone payments tied to the
commercial use of the reagents.
Futher financial details were not disclosed.
LabCorp will initially use the reagents for laboratory-developed,
stool-based testing in North America.
nina.chestney@thomsonreuters.com
nc/ejp
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|